IMMEDIATE NOTIFICATION OF PUBLIC HEALTH AUTHORITIES
Vaccine administered up to 3 days post-exposure was effective in preventing infection as well as lessening the severity of the disease if infection occurred 
Vaccinia Vaccine (administer within 72hrs of exposure)
Supportive care and wound care for open lesions
Vaccinia Vaccine within the first 72hrs can decrease total disease severity and within 7 days may decrease symptoms
Vaccination is not efficacious once the patient has developed rash
Vaccination is not efficacious once the patient has developed rash
Bioterrorism antibiotics
Immunocompromised antibiotics
Blister chemical agents
Sepsis antibiotics
Arthropod and parasitic antibiotics
Skin and soft tissue antibiotics
Beta-lactams
GU antibiotics